Health
Reuters exclusively reported[1] that U.S. drugmaker Eli Lilly LLY.N[2] expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review.
Market